Paralysis strikes at the very heart of what it means to be human.

It’s not just the lack of feeling and movement, it also interferes with the body’s internal systems that are designed to keep people alive. Multiple infections, neuropathic pain and uncontrollable spasms are common. These are the things that exhaust even the most determined. And, along with fundamentally impacting quality of life, it comes with €4 million average lifetime cost of care, there are huge barriers to getting back to work, and premature death is inevitable.

Everything Collaborative Cures does is about bringing people together to cure paralysis in our lifetime which will produce a public benefit for up to 60 million people around the world with some form of paralysis.


Many of the world’s greatest scientists and technologists have discovered breakthroughs that have the potential to impact paralysed people’s lives today. Yet, these interventions are held hostage in the minds and labs of these spectacular researchers due to systemic failures in translating research from the lab to the clinic.

This impacts the lives of 60 million people around the world suffering from some kind of paralysis who have no access to any meaningful therapies.

No individual scientist, technologist, entrepreneur, investor or philanthropist is going to cure paralysis on their own. But by working together, they will.

So, through Collaborative Cures, we’re focused on bringing people together to create systemic impact that will:

  • Reduce 50-year scientific translation timelines to 10 years by creating the conditions for collaboration, facilitating healthy rivalries and building trust.
  • Catalyse collaborations worth €1 billion by connecting scientists and technologists with business know how, regulatory expertise and capital.

Ultimately, the goal is to release meaningful therapies from the lab to the clinic so that they are readily available to the people who need them most.

Delivering Outcomes

Our strategy is designed to bring people together to cure paralysis in our lifetime. To do it, our plan focuses on the following outcomes:



We are co-creating research insights and learning modules with an interdisciplinary knowledge network of leadership experts, negotiation practitioners, performance psychologists and behavioural scientists to understand how to tackle systematic fragmentation.



We are inspiring early to mid-career scientists, technologists, entrepreneurs, investors and philanthropists to create the conditions for collaboration, facilitate healthy rivalries and build trust.



We are systematically identifying, mapping and building relationships with leading scientists, technologists, entrepreneurs, investors and philanthropists around the world to catalyse collaborations worth €1 billion.